National trends and determinants of proton therapy use for prostate cancer: A National Cancer Data Base study

CONCLUSIONSThe use of proton therapy to treat patients with prostate cancer more than doubled from 2004 to 2012, with striking racial disparities in its use noted despite robust multivariable adjustments. Long‐term follow‐up is needed to determine whether the increased use of proton therapy for prostate cancer is justified, and ongoing efforts should be made to ensure equal access to resource‐limited oncologic therapies. Cancer 2016. © 2016 American Cancer Society.

Source: Cancer - March 11, 2016 Category: Cancer & Oncology Authors: Brandon A. Mahal, Yu‐Wei Chen, Jason A. Efstathiou, Vinayak Muralidhar, Karen E. Hoffman, James B. Yu, Felix Y. Feng, Clair J. Beard, Neil E. Martin, Peter F. Orio, Paul L. Nguyen Tags: Original Article Source Type: research